Systemic steroids may enhance recovery from loss of smell and taste in hospitalized coronavirus disease 2019 (COVID-19) patients: an observational study.
作者信息
Locatello Luca Giovanni, Trotta Benedetta, Bruno Chiara, Trotta Michele, Maggiore Giandomenico, Rasero Laura, Caini Saverio, Gallo Oreste
机构信息
Department of Otorhinolaryngology, Careggi University Hospital, Florence, Italy.
Department of Infectious and Tropical Diseases, Careggi University Hospital, Florence, Italy.
出版信息
Int Forum Allergy Rhinol. 2021 Dec;11(12):1689-1693. doi: 10.1002/alr.22848. Epub 2021 Jun 16.
Abstract
摘要
相似文献
1
Systemic steroids may enhance recovery from loss of smell and taste in hospitalized coronavirus disease 2019 (COVID-19) patients: an observational study.
Int Forum Allergy Rhinol. 2021 Dec;11(12):1689-1693. doi: 10.1002/alr.22848. Epub 2021 Jun 16.
2
Loss of Smell and Taste Among Healthcare Personnel Screened for Coronavirus 2019.
Clin Infect Dis. 2021 Apr 8;72(7):1244-1246. doi: 10.1093/cid/ciaa877.
3
Acute Loss of Smell or Taste Without Nasal Blockage Should Raise Suspicion for COVID-19 Infection.
J Evid Based Dent Pract. 2021 Mar;21(1):101525. doi: 10.1016/j.jebdp.2020.101525. Epub 2021 Jan 25.
4
Taste and smell as chemosensory dysfunctions in COVID-19 infection.
Am J Dent. 2020 Jun;33(3):135-137.
5
Regarding Use of Topical Steroids in Patients With COVID-19-Associated Olfactory Loss.
JAMA Otolaryngol Head Neck Surg. 2021 Jan 1;147(1):110. doi: 10.1001/jamaoto.2020.4275.
6
Prevalence of Loss of Smell and/or Taste and other Otorhinolaryngology Symptoms in COVID-19 Patients.
Kathmandu Univ Med J (KUMJ). 2021 Apr-Jun;19(74):173-179.
7
Sudden onset, acute loss of taste and smell in coronavirus disease 2019 (COVID-19): a systematic review.
Acta Odontol Scand. 2020 Aug;78(6):467-473. doi: 10.1080/00016357.2020.1787505. Epub 2020 Aug 7.
8
New onset of loss of smell or taste in household contacts of home-isolated SARS-CoV-2-positive subjects.
Eur Arch Otorhinolaryngol. 2020 Sep;277(9):2637-2640. doi: 10.1007/s00405-020-06066-9. Epub 2020 May 24.
9
Alteration of Smell and Taste in Asymptomatic and Symptomatic COVID-19 Patients in Sicily, Italy.
Ear Nose Throat J. 2021 Apr;100(2_suppl):182S-185S. doi: 10.1177/0145561320981447. Epub 2020 Dec 22.
10
Anosmia (smell failure) and dysgeusia (taste distortion) in COVID-19: it is genetic.
J Biomol Struct Dyn. 2023 Apr;41(7):3162-3165. doi: 10.1080/07391102.2022.2039773. Epub 2022 Feb 11.
引用本文的文献
1
Case Report: Acupuncture is an effective treatment for olfactory dysfunction in the post COVID-19 condition.
Front Neurol. 2022 Aug 23;13:916944. doi: 10.3389/fneur.2022.916944. eCollection 2022.
2
Persisting Smell and Taste Disorders in Patients Who Recovered from SARS-CoV-2 Virus Infection-Data from the Polish PoLoCOV-CVD Study.
Viruses. 2022 Aug 12;14(8):1763. doi: 10.3390/v14081763.
3
Results from psychophysical tests of smell and taste during the course of SARS-CoV-2 infection: a review.
Acta Otorhinolaryngol Ital. 2022 Apr;42(Suppl. 1):S20-S35. doi: 10.14639/0392-100X-suppl.1-42-2022-03.
本文引用的文献
1
Risk factors and characteristics associated with persistent smell loss in coronavirus disease 2019 (COVID-19) patients.
Int Forum Allergy Rhinol. 2021 Aug;11(8):1280-1282. doi: 10.1002/alr.22802. Epub 2021 Apr 17.
2
Systemic corticosteroids in coronavirus disease 2019 (COVID-19)-related smell dysfunction: an international view.
Int Forum Allergy Rhinol. 2021 Jul;11(7):1041-1046. doi: 10.1002/alr.22788. Epub 2021 Mar 16.
3
Attributes and predictors of long COVID.
Nat Med. 2021 Apr;27(4):626-631. doi: 10.1038/s41591-021-01292-y. Epub 2021 Mar 10.
4
The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients.
Am J Otolaryngol. 2021 May-Jun;42(3):102892. doi: 10.1016/j.amjoto.2020.102892. Epub 2021 Jan 16.
5
Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell.
Eur Arch Otorhinolaryngol. 2021 Aug;278(8):3113-3117. doi: 10.1007/s00405-020-06520-8. Epub 2021 Jan 9.
6
Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients.
J Intern Med. 2021 Aug;290(2):451-461. doi: 10.1111/joim.13209. Epub 2021 Jan 5.
7
A systematic review of corticosteroid treatment for noncritically ill patients with COVID-19.
Sci Rep. 2020 Dec 1;10(1):20935. doi: 10.1038/s41598-020-78054-2.
8
The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection.
Mucosal Immunol. 2021 Mar;14(2):305-316. doi: 10.1038/s41385-020-00359-2. Epub 2020 Nov 26.
9
Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection.
JAMA. 2020 May 26;323(20):2089-2090. doi: 10.1001/jama.2020.6771.
10
Cerebral Vascular Toxicity of Antiretroviral Therapy.
J Neuroimmune Pharmacol. 2021 Mar;16(1):74-89. doi: 10.1007/s11481-019-09858-x. Epub 2019 Jun 17.
Zotero 插件